Trial Profile
Impact of Anticoagulation Therapy on the Cognitive Decline and Dementia in Patients With Non-Valvular Atrial Fibrillation (CAF Trial)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Sep 2021
Price :
$35
*
At a glance
- Drugs Dabigatran etexilate (Primary) ; Warfarin
- Indications Thromboembolism
- Focus Pharmacodynamics
- Acronyms CAF Trial; Vanguard study
- 30 Aug 2021 Status changed from active, no longer recruiting to completed.
- 01 Apr 2021 Status changed from recruiting to active, no longer recruiting.
- 01 Apr 2019 As of 27 feb 2019, n= 97 subjects have been enrolled in the study as per trial design published in the Clinical Cardiology.